4 completed, 1 available, 1 recruiting. 4 Phase 1, 1 Phase 2.
By phase and status
Follow BAY2927088: new trials by email Literature Review of BAY2927088 trials Research Report on BAY2927088
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix .
Trial Phase Status Sponsor Enrollment Start Updated
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) BAY2927088 - Advanced Solid Tumors, HER2 Mutation Phase 2 Recruiting 111 2025-02-13 2026-11-04
A Study to Learn About How BAY2927088 Affects the Level of Midazolam in the Blood When Both Drugs Are Taken Together in Healthy Participants BAY2927088, Midazolam - Advanced Non-small Cell Lung Cancer, EGFR Mutation Phase 1 Completed 15 2024-04-17 2024-07-03
A Study to Learn About How Itraconazole and Carbamazepine Affect the Level of BAY2927088 in the Blood When These Drugs Are Taken Together by Healthy Participants BAY2927088, Itraconazole, Carbamazepine - Advanced Non-small Cell Lung Cancer, EGFR Mutation Phase 1 Completed 30 2024-04-10 2024-06-20
A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants BAY2927088, Esomeprazole, Food - Advanced Non-small Cell Lung Cancer, EGFR Mutation Phase 1 Completed 21 2024-03-29 2024-07-05
A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy Participants BAY2927088, Dabigatran etexilate, Rosuvastatin - Advanced Non-small Cell Lung Cancer, EGFR Mutation Phase 1 Completed 15 2024-03-25 2024-07-05
Expanded Access to Provide Sevabertinib (BAY 2927088) for the Treatment of Locally Advanced or Metastatic NSCLC With HER2 Mutation Sevabertinib - Advanced Non-small Cell Lung Cancer, Cancer Available 2026-07-07
Conditions studied Biliary Tract Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Endometrial Neoplasms (1) · Esophageal Neoplasms (1) · Gallbladder Neoplasms (1) · Gastrointestinal Neoplasms (1) · Gastrointestinal Stromal Tumors (1) · Neoplasms (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Sarcoma (1) · Stomach Neoplasms (1) · Urinary Bladder Neoplasms (1)
Sponsors Bayer (6)
Countries United States (4) · Australia (1) · Canada (1) · China (1) · Denmark (1) · France (1) · Italy (1) · Japan (1) · South Korea (1) · Spain (1) · Switzerland (1) · United Kingdom (1)